Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
October, 2026
October 2026
M T W T F S S
 1234
567891011
12131415161718
19202122232425
262728293031  
Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association
Oct 2, 2026, 16:02

Advancing Antithrombotic Stewardship to Optimise Care – American Heart Association

American Heart Association shared a post on LinkedIn about a recent article by Kelly Rudd et al, adding:

“Antithrombotic therapy is a cornerstone in the approach to reducing the complications of several vascular disorders, including atrial fibrillation (AF), venous thromboembolic disease (VTE), and peripheral vascular disease (PVD). However, balancing the benefits of thrombosis prevention and risks, particularly of medication-related bleeding, is a significant concern for healthcare providers.

Addressing antithrombotic undertreatment requires sustained system-level change, expansion of antithrombotic stewardship, improved access to therapy, and focused efforts within at-risk populations. As healthcare teams continue to strengthen interdisciplinary collaboration and integrate evidence-based, stewardship strategies, meaningful progress can be achieved in reducing preventable thrombotic events and improving long-term patient outcomes across AF, VTE, and PAD.

Summary of the impa.”

Title: Impact of Undertreated Antithrombotic Therapy on Adverse Patient Outcomes: A Scientific Statement From the American Heart Association

Authors: Kelly Rudd, Youssef Bessada, Geoffrey Barnes, Ulf Bronas, Ashley Budd, Taylor Goot, Natalie Montanez, Toby Trujillo

Advancing Antithrombotic Stewardship to Optimise Care - American Heart Association

Stay updated on all scientific advances with Hemostasis Today.

AF American Heart Association Ashley Budd Atrial Fibrillation Geoffrey Barnes Kelly Rudd Natalie Montanez peripheral vascular disease PVD Taylor Goot Toby Trujillo Ulf Bronas Venous Thromboembolic Disease VTE Youssef Bessada
NewsFeed